These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32658968)

  • 1. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro B
    Clin Infect Dis; 2020 Sep; 71(6):1361-1364. PubMed ID: 32658968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM
    Pharmacotherapy; 2020 Apr; 40(4):363-367. PubMed ID: 32227354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM
    Am J Health Syst Pharm; 2020 May; 77(11):835-864. PubMed ID: 32191793
    [No Abstract]   [Full Text] [Related]  

  • 4. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise T; Levine D; Bradley J; Liu C; Mueller B; Pai M; Wong-Beringer A; Rotschafer JC; Rodvold K; Maples HD; Lomaestro BM
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):281-284. PubMed ID: 32659787
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Lomaestro BM; Rotschafer JC; Moellering RC; Craig WA; Billeter M; Dalovisio JR; Levine DP
    Pharmacotherapy; 2009 Nov; 29(11):1275-9. PubMed ID: 19873687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin.
    Murphy M; Girdwood ST; Scheetz MH
    J Hosp Med; 2020 Dec; 15(12):740-742. PubMed ID: 33231544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?
    Patel K; Crumby AS; Maples HD
    Paediatr Drugs; 2015 Apr; 17(2):97-103. PubMed ID: 25644329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Therapeutic Vancomycin Monitoring in Taiwan.
    Chen TT; Liu MP; Sun HC
    Microbiol Spectr; 2022 Apr; 10(2):e0156221. PubMed ID: 35412391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Lomaestro BM; Rotschafer JC; Moellering RC; Craig WA; Billeter M; Dalovisio JR; Levine DP
    Clin Infect Dis; 2009 Aug; 49(3):325-7. PubMed ID: 19569969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First.
    Lodise TP; Drusano G
    Clin Infect Dis; 2021 May; 72(9):1497-1501. PubMed ID: 33740042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the Clinical Use of Vancomycin.
    Álvarez R; López Cortés LE; Molina J; Cisneros JM; Pachón J
    Antimicrob Agents Chemother; 2016 May; 60(5):2601-9. PubMed ID: 26856841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?
    Hale CM; Seabury RW; Steele JM; Darko W; Miller CD
    J Pharm Pract; 2017 Jun; 30(3):329-335. PubMed ID: 27074786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of AUC-Based Monitoring on Pharmacist-Directed Vancomycin Dose Adjustments in Complicated Methicillin-Resistant
    Stoessel AM; Hale CM; Seabury RW; Miller CD; Steele JM
    J Pharm Pract; 2019 Aug; 32(4):442-446. PubMed ID: 29554847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
    Tsutsuura M; Moriyama H; Kojima N; Mizukami Y; Tashiro S; Osa S; Enoki Y; Taguchi K; Oda K; Fujii S; Takahashi Y; Hamada Y; Kimura T; Takesue Y; Matsumoto K
    BMC Infect Dis; 2021 Feb; 21(1):153. PubMed ID: 33549035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dosing and monitoring of vancomycin: what is the best way forward?
    Drennan PG; Begg EJ; Gardiner SJ; Kirkpatrick CMJ; Chambers ST
    Int J Antimicrob Agents; 2019 Apr; 53(4):401-407. PubMed ID: 30599240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
    Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
    J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
    Song KH; Kim HB; Kim HS; Lee MJ; Jung Y; Kim G; Hwang JH; Kim NH; Kim M; Kim CJ; Choe PG; Chung JY; Park WB; Kim ES; Park KU; Kim NJ; Kim EC; Oh MD
    Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Vancomycin Bayesian-Estimated Area Under the Curve Versus Trough-Based Dosing.
    Cerenzio J; Truong J
    Ann Pharmacother; 2023 Aug; 57(8):931-939. PubMed ID: 36476049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP
    Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin Therapeutic Drug Monitoring in Children: New Recommendations, Similar Challenges.
    McNeil JC; Kaplan SL
    J Pediatr Pharmacol Ther; 2020; 25(6):472-475. PubMed ID: 32839650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.